Section one: Contracting authority/entity
one.1) Name and addresses
NHS Blood & Transplant
North Bristol Park
Filton, Bristol
Telephone
+44 7385387928
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Supply of Whole Blood Collection System and Ancillary Processing Systems
Reference number
NHSBT0763
two.1.2) Main CPV code
- 33141613 - Blood bags
two.1.3) Type of contract
Supplies
two.2) Description
two.2.1) Title
Whole Blood Collection Systems (Lot 1) and Ancillary Processing Systems (Lot2)
two.2.2) Additional CPV code(s)
- 33141630 - Blood plasma filters
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
United Kingdom, Ireland, Australia, and New Zealand
two.2.4) Description of the procurement at the time of conclusion of the contract:
On the 9th June 2017, this tender (EuroBloodPack 2) for the Supply Whole Blood and Ancillary Processing Systems was awarded under a Framework Agreement with the notice number https://ted.europa.eu/udl?uri=TED:NOTICE:155066-2016:TEXT:EN:HTML with subsequent contract award notice 2017/S 128-260952 https://ted.europa.eu/udl?uri=TED:NOTICE:260952-2017:TEXT:EN:HTML
EuroBloodPack 2 was run by NHSBT, working with other European Blood Alliance members (full details of the EBA and their members are available at www.europeanbloodalliance.eu/ updated from time to time), the Australian Blood Service (ARCBS) and New Zealand Blood Service (NZBS) who were all potential beneficiaries to the agreement. To note, those beneficiaries are eligible to place orders but not mandated.
EuroBloodPack 2 is divided in two Lots respectively: Whole Blood Collection System (Lot 1) and Ancillary Processing System (Lot 2).
Lot No 1: To supply Bottom and Top, Top and Top and Dry Packs.
Lot No 2:To supply: Quadruple transfer system for the storage of platelets for neonatal use, Quadruple transfer system for the storage of frozen plasma for neonatal use, Quadruple transfer system for the storage of red cells for neonatal use, Sextuplet transfer system for the storage of red cells for neonatal use, Single transfer pack for the handling of waste material or storage of plasma components, Cryoprecipitate pooling system, Plasma filter system — single storage pack, In-process filter system for platelets, Platelet storage system, Platelet pooling filter system, Platelet pooling filter system incorporating integral sampling device.
two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession
Start date
9 June 2017
End date
31 March 2023
In the case of framework agreements, provide justification for any duration exceeding 4 years
Need for modification brought about by circumstances which a diligent contracting authority could not foresee. See sections VII2.1 and VII2.2
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.2) Administrative information
four.2.1) Contract award notice concerning this contract
Notice number: 2017/S 128-260952
Section five. Award of contract/concession
Contract No
NHSBT0763
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract/concession award decision:
9 June 2017
five.2.2) Information about tenders
The contract/concession has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
MacoPharma GMP.b, Haemonetics S.A, Fresenius Kabi Limited
Mouscron, Runcorn, Signy
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)
Total value of the procurement: £70,000,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
High Courts of Justice
London
Country
United Kingdom
Section seven: Modifications to the contract/concession
seven.1) Description of the procurement after the modifications
seven.1.1) Main CPV code
- 33141613 - Blood bags
seven.1.2) Additional CPV code(s)
- 33141630 - Blood plasma filters
seven.1.3) Place of performance
NUTS code
- UK - United Kingdom
Main site or place of performance
United Kingdom, Ireland, Australia, and New Zealand
seven.1.4) Description of the procurement:
The EuroBloodPack 2(EBP2) framework agreement has a duration of four years and is due to expire on the 9th June 2021. This Modification will extend the EBP2 Framework Agreement to 31st March 2023.
seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession
Start date
9 June 2017
End date
31 March 2023
In the case of framework agreements, provide justification for any duration exceeding 4 years:
See sections VII2.1 and VII2.2
seven.1.6) Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession:
£70,000,000
seven.1.7) Name and address of the contractor/concessionaire
MacoPharma GMP.b, Haemonetics S.A, Fresenius Kabi Limited
Mouscron, Runcorn, Signy
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
seven.2) Information about modifications
seven.2.1) Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):
The EuroBloodPack 2(EBP2) framework agreement has a duration of four years and is due to expire on the 9th June 2021. This Modification will extend the EBP2 Framework until 31st March 2023. Due to the impact of Covid-19 and the support for the Convalescent Plasma (CVP) programme there has been a significant delay in the retendering the new supply and in developing the replacement International Blood Pack 1 (IBP1) Framework on time.
seven.2.2) Reasons for modification
Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee.
Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:
This Modification Notice is to provide notice that the EBP2 is being modified in accordance with Regulation 72 .1. B and /or 72.1.C of the Public Contracts Regulations 2015. This is because of the continuing focus of the contracting authorities on the Covid-19 crisis (which no diligent contracting authority could have foreseen) has significantly reduced the technical support for a retender. The length of this time has been chosen so that the replacement Framework IBP1can be completed. The length of time of this extension is because any other interim arrangements would be in place for such a short duration that it would cause significant inconvenience and/ or substantial duplication of costs; along with causing significant technical barriers such as requirements of interchangeability or interoperability with existing equipment, services or installations procured under the initial procurement.
seven.2.3) Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)
Value excluding VAT: £70,000,000
Total contract value after the modifications
Value excluding VAT: £104,000,000